Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2006 1
2007 1
2008 1
2011 4
2012 1
2013 2
2015 2
2017 3
2018 3
2019 1
2020 2
2021 2
2022 1
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.
Mateos MV, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Chiu C, Wang J, Carson R, Crist W, Deraedt W, Nguyen H, Qi M, San-Miguel J; ALCYONE Trial Investigators. Mateos MV, et al. N Engl J Med. 2018 Feb 8;378(6):518-528. doi: 10.1056/NEJMoa1714678. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231133 Free article. Clinical Trial.
Biclonal myeloma in renal failure.
Nikolova-Vlahova MK, Kamburova M, Hristova J, Vasileiou D, Bogov B, Krasteva R, Hadjiev E, Tsvetkova G, Vasileva C, Houbanov N. Nikolova-Vlahova MK, et al. Among authors: hadjiev e. Cent Eur J Immunol. 2020;45(1):122-124. doi: 10.5114/ceji.2020.94714. Cent Eur J Immunol. 2020. PMID: 32425690 Free PMC article.
Calreticulin Mutations in Bulgarian MPN Patients.
Pavlov I, Hadjiev E, Alaikov T, Spassova S, Stoimenov A, Naumova E, Shivarov V, Ivanova M. Pavlov I, et al. Among authors: hadjiev e. Pathol Oncol Res. 2018 Jan;24(1):171-174. doi: 10.1007/s12253-017-0226-2. Epub 2017 Apr 14. Pathol Oncol Res. 2018. PMID: 28411309 Free article.
Probable HLA-mediated immunoediting of JAK2 V617F-driven oncogenesis.
Ivanova M, Tsvetkova G, Lukanov T, Stoimenov A, Hadjiev E, Shivarov V. Ivanova M, et al. Among authors: hadjiev e. Exp Hematol. 2020 Dec;92:75-88.e10. doi: 10.1016/j.exphem.2020.09.200. Epub 2020 Oct 2. Exp Hematol. 2020. PMID: 33017633 Free article.
Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial.
Cochrane T, Enrico A, Gomez-Almaguer D, Hadjiev E, Lech-Maranda E, Masszi T, Nikitin E, Robak T, Weinkove R, Wu SJ, Sail KR, Pesko J, Pai M, Komlosi V, Anderson MA. Cochrane T, et al. Among authors: hadjiev e. Leuk Lymphoma. 2022 Feb;63(2):304-314. doi: 10.1080/10428194.2021.1986217. Epub 2021 Oct 11. Leuk Lymphoma. 2022. PMID: 34632935 Clinical Trial.
Is There a Link Between Changes in Levels of Hepcidin and Stroke?
Petrova JJ, Manolov VE, Hadjidekova SP, Hadjiev EA, Bogov BI, Marinov BM, Vasilev VG, Tzatchev KN. Petrova JJ, et al. Among authors: hadjiev ea. Clin Lab. 2015;61(12):1935-9. doi: 10.7754/clin.lab.2015.150522. Clin Lab. 2015. PMID: 26882818
Updated quality of life data from the phase 3b VENICE II trial: patients with relapsed or refractory chronic lymphocytic leukemia receiving venetoclax monotherapy.
Cochrane T, Enrico A, Gomez-Almaguer D, Hadjiev E, Lech-Maranda E, Masszi T, Nikitin E, Robak T, Weinkove R, Wu SJ, Manzoor BS, Busman T, Pai M, Komlosi V, Anderson MA. Cochrane T, et al. Among authors: hadjiev e. Leuk Lymphoma. 2023 Aug 25:1-4. doi: 10.1080/10428194.2023.2247511. Online ahead of print. Leuk Lymphoma. 2023. PMID: 37626019 No abstract available.
26 results